Given the high expression levels of ofCS and EpCAM, and the relatively low expression of PD-L1 and EGFR, the combination of rVAR2 and EpCAM was chosen for optimal targeting and enrichment of NSCLC cells. Here, CD274 is linked to non-small cell lung carcinoma.